🔴 Nasus Pharma is trading 10.1% down today with catalyst unclear

Nasus Pharma is trading 10.1% down at $3.39 after opening-session weakness on September 3, 2026; the catalyst remains unclear.

• No new company-specific announcement dated September 3 was identified, and the investor-relations news page shows no clearly matching catalyst.
• The decline contrasts with stronger broader markets and healthcare-sector gains, so global or sector sentiment does not clearly explain it.
• Company-specific selling or low-liquidity trading is the most likely explanation.